Glucotrack GCTK
Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001493152-26-043844
- Makes a Regulation FD disclosure (7.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.
- Aethlon Medical AEMD public float $6M, Sep 30, 2025
- Family Office of America FOFA public float $6M, Jun 30, 2025
- Odyssey Health ODYY public float $6M, Jan 31, 2026
- Autonomix Medical AMIX public float $6M, Sep 30, 2025
- Sonoma Pharmaceuticals SNOA public float $6M, Sep 30, 2025
